Sort
51,570 grants matching “autoimmune disease”
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,395,617Julie R Park · Seattle Children'S Hospital · U01 · FY2022 · TR
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,394,078Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Novel Transfusion Based Immune Modulation
$1,394,062Stanford University · P01 · FY2002 · HL
Toll-Like Receptors in Systemic Autoimmune Disease
$1,393,290Ann Marshak-Rothstein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · AR
High Throughput Next Generation Sequencing: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases.
$1,392,696Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2021 · AR
Antigen Specific Therapy in CNS Autoimmune Diseases
$1,392,420Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2007 · NS
Normal And Pathologic Mechanisms Of Inflammation, Innate And Acquired Immunity
$1,391,554Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,390,827Julie R Park · Seattle Children'S Hospital · U01 · FY2021 · TR
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches
$1,390,253Stephen S. Rich · University Of Virginia · R01 · FY2020 · DK
Host Immunity Against Bacteria
$1,389,789Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Role of co-receptor modified cells in HIV infection
$1,388,771Carl H. June · University Of Pennsylvania · U01 · FY2016 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,388,137Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,387,317Scripps Research Institute · P01 · FY2003 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,387,317Scripps Research Institute · P01 · FY2004 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,387,317Scripps Research Institute · P01 · FY2002 · DK
Helicobacter pylori Pathogenesis Studies
$1,386,563William Coleman · National Institute On Minority Health And Health Disparities · ZIA · FY2014 · MD
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,386,496Julie R Park · Seattle Children'S Hospital · U01 · FY2020 · TR
Thymectomy in Non-Thymomatous MG Patients on Prednisone
$1,386,419University Of Alabama At Birmingham · U01 · FY2005 · NS
SLE Treatment with N-acetylcysteine
$1,386,367Andras Perl · Upstate Medical University · U01 · FY2021 · AR
USIDNET: A resource for clinical immunologists
$1,386,366Kathleen E Sullivan · Children'S Hosp Of Philadelphia · R24 · FY2025 · AI
CO-FUNDING-NIAID
$1,385,407Ann Marshak-Rothstein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · AR
Clinical Site Monitoring Group
$1,384,677Lauren Sherwood · Rho Federal Systems Division, Inc. · UM2 · FY2017 · AI
BLOOD GROUP ANTIGENS IN HEALTH AND DISEASE
$1,384,493New York Blood Center · P50 · FY2002 · HL
Signaling via MHC: engineering immune cells with new capabilities
$1,383,783Alok Joglekar · University Of Pittsburgh At Pittsburgh · DP2 · FY2022 · AI
AMP RA/SLE Leadership Center
$1,383,702Paul Joseph Utz · Stanford University · UM2 · FY2017 · AR